Segment disclosures

Company overview

SEQUENOM INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

2 dimension combinations 6 retained observations 4 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Genetic Analysis

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sqnm:GeneticAnalysisMember
PeriodValueUnitFiledEvidence
2012-01-01 – 2012-12-3143240000 USD20130402Open filing evidence
2011-01-01 – 2011-12-3147588000 USD20130402Open filing evidence
2010-01-01 – 2010-12-3144905000 USD20130402Open filing evidence

Sequenom Bioscience

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=sqnm:SequenomBioscienceMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-3142870000 USD20140227Open filing evidence
2012-01-01 – 2012-12-3143240000 USD20140227Open filing evidence
2011-01-01 – 2011-12-3147588000 USD20140227Open filing evidence